Literature DB >> 28551410

Perceptions and attitudes of community pharmacists toward professional ethics and ethical dilemmas in the workplace.

Jadranka Vuković Rodríguez1, Živka Juričić2.   

Abstract

BACKGROUND: Formal training in pharmacy ethics is relatively new in Croatia, and the professional code of ethics is more than 20 years old. Very little is known about how practicing pharmacists implement ethical considerations and relevant professional guidelines in their work.
OBJECTIVES: This study aimed to provide the first description of the perceptions and attitudes of Croatian community pharmacists toward ethics in pharmacy practice, how often they face certain ethical dilemmas and how they resolve them.
METHODS: A cross-sectional survey of 252 community pharmacists, including community pharmacists and pre-licensing trainees, was conducted in Zagreb, Croatia. This group accounts for 18% of licensed pharmacists in Croatia. The survey questions included four sections: general sociodemographic information, multiple-choice questions, pre-defined ethical scenarios, and ethical scenarios filled in by respondents.
RESULTS: More than half of pharmacists (62.7%) face ethical dilemmas in everyday work. Nearly all (94.4%) are familiar with the current professional code of ethics in Croatia, but only 47.6% think that the code reflects the changes that the pharmacy profession faces today. Most pharmacists (83.3%) solve ethical dilemmas on their own, while nearly the same proportion (75.4%) think that they are not adequately trained to deal with ethical dilemmas. The pre-defined ethical scenarios experienced by the largest proportion of pharmacists are being asked to dispense a drug to someone other than the patient (93.3%), an unnecessary over-the-counter medicine (84.3%), a generic medicine clinically equivalent to the prescribed one (79.4%), or hormonal contraception over the counter (70.4%).
CONCLUSIONS: The results demonstrate a need to improve formal pharmacy ethics education and training in how to assess ethical issues and make appropriate decisions, which implies the need for stronger collaboration between pharmacists and their professional association. Our results also highlight an urgent need to revise and update the Croatian code of ethics for pharmacists.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Code of ethics; Community pharmacy; Ethical issues/dilemmas; Pharmacy values

Mesh:

Year:  2017        PMID: 28551410     DOI: 10.1016/j.sapharm.2017.05.010

Source DB:  PubMed          Journal:  Res Social Adm Pharm        ISSN: 1551-7411


  5 in total

1.  A Distance-Learning Course to Improve Drug-Dispensing Behaviors Among Brazilian Community Pharmacists.

Authors:  Tiago Marques Dos Reis; André de Oliveira Baldoni; Alessandra Menezes Campos; Edmarlon Girotto; Camilo Molino Guidoni; Paulo Roque Obreli-Neto; Leonardo Régis Leira Pereira
Journal:  Am J Pharm Educ       Date:  2019-10       Impact factor: 2.047

2.  Community pharmacy ethical practice in Jordan: assessing attitude, needs and barriers.

Authors:  Rajaa A Al-Qudah; Omar Tuza; Haneen Tawfiek; Betty Chaar; Iman A Basheti
Journal:  Pharm Pract (Granada)       Date:  2019-03-17

3.  Perspectives of Pharmacy Graduates Toward an Undergraduate Ethics Course and Its Potential Impact on Their Professional Practice.

Authors:  Nadir Kheir; Ahmed Awaisu; Sohayla Ibrahim; Sara Murshid Al-Dulaimi; Hoda Gad
Journal:  Adv Med Educ Pract       Date:  2019-12-13

4.  Assessment of Community Pharmacy Professionals' Attitude and Perception Towards Ethical Issues in Amhara Region, Ethiopia: A Cross-Sectional Survey 2020.

Authors:  Wudneh Simegn; Berhanemeskel Weldegerima; Alem Endeshaw; Gashaw Sisay; Abdulwase Mohammed; Dawit Wondimsigegn; Henok Dagne
Journal:  Risk Manag Healthc Policy       Date:  2021-10-02

5.  Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers.

Authors:  Mohamed Bahlol; Mary Bushell; Hani M J Khojah; Rebecca Susan Dewey
Journal:  Saudi Pharm J       Date:  2022-04-19       Impact factor: 4.562

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.